Warby Parker Inc Ordinary Shares - Class A WRBY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Warby Parker Announces Participation in the Goldman Sachs 31st Annual Global Retailing Conference
-
Warby Parker narrows net loss as eyewear retailer's revenue jumps
-
Warby Parker Announces Second Quarter 2024 Results
-
Warby Parker appoints Ronald A. Williams as Lead Director and welcomes Bradley E. Singer to Board of Directors
-
Warby Parker to Announce Second Quarter 2024 Financial Results on August 8, 2024
-
Warby Parker's stock sees biggest gain in nearly two years company raises guidance, overshadowing a quarterly loss
-
Warby Parker's stock tumbles again after earnings, as gross margins keep falling
-
Warby Parker's stock suffers record selloff as margins were hurt by contact lens sales strength
Trading Information
- Previous Close Price
- $16.33
- Day Range
- $15.58–16.40
- 52-Week Range
- $9.83–17.95
- Bid/Ask
- $15.50 / $18.00
- Market Cap
- $1.87 Bil
- Volume/Avg
- 1.2 Mil / 1.6 Mil
Key Statistics
- Price/Earnings (Normalized)
- 645.51
- Price/Sales
- 2.70
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Warby Parker Inc is engaged in designing and developing designer prescription glasses and contacts, and providing the facility of eye exams and vision tests. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 3,491
- Website
- https://www.warbyparker.com
Comparables
Valuation
|
Metric
|
WRBY
|
301101
|
300622
|
|---|---|---|---|
Price/Earnings (Normalized) | 645.51 | 39.17 | 50.49 |
Price/Book Value | — | 3.50 | 6.80 |
Price/Sales | 2.70 | 7.23 | 4.28 |
Price/Cash Flow | 28.40 | 27.56 | 18.12 |
Price/Earnings
WRBY
301101
300622
Financial Strength
|
Metric
|
WRBY
|
301101
|
300622
|
|---|---|---|---|
Quick Ratio | 1.98 | 9.29 | 1.01 |
Current Ratio | 2.55 | 10.08 | 2.08 |
Interest Coverage | — | 575.06 | 18.35 |
Quick Ratio
WRBY
301101
300622
Profitability
|
Metric
|
WRBY
|
301101
|
300622
|
|---|---|---|---|
Return on Assets (Normalized) | 0.74% | 8.07% | 8.90% |
Return on Equity (Normalized) | — | 9.11% | 13.32% |
Return on Invested Capital (Normalized) | −0.76% | 9.10% | 10.59% |
Return on Assets
WRBY
301101
300622
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| Rbqrnwwmr | Gclxk | $174.6 Bil | |||
| Becton Dickinson & Co
BDX
| Dfcdfgwcs | Yfnpsy | $69.7 Bil | |||
| Alcon Inc
ALC
| Lvjkjrh | Yvxltl | $49.4 Bil | |||
| ResMed Inc
RMD
| Wbvtcqqmm | Rgylyd | $35.9 Bil | |||
| Coloplast AS ADR
CLPBY
| Tqycjhqft | Vzpz | $29.5 Bil | |||
| The Cooper Companies Inc
COO
| Dgzxlyxth | Gmqqvn | $22.0 Bil | |||
| West Pharmaceutical Services Inc
WST
| Zykblggrmb | Mcf | $21.8 Bil | |||
| Baxter International Inc
BAX
| Nmczmqg | Gzvwrf | $19.4 Bil | |||
| Align Technology Inc
ALGN
| Mtggmkqx | Sdhkrfm | $19.0 Bil | |||
| Hologic Inc
HOLX
| Zhpxvck | Hkxtz | $18.9 Bil |
United States